arsenic trioxide has been researched along with isomethyleugenol in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (13.33) | 18.7374 |
| 1990's | 2 (13.33) | 18.2507 |
| 2000's | 4 (26.67) | 29.6817 |
| 2010's | 6 (40.00) | 24.3611 |
| 2020's | 1 (6.67) | 2.80 |
| Authors | Studies |
|---|---|
| Boeckx, M; Buchet, JP; Lauwerys, R; Offergelt, JA; Roels, H | 1 |
| Mashiko, M; Takahashi, K; Yamamura, Y; Yamauchi, H | 1 |
| Yamamura, Y; Yamauchi, H | 1 |
| Farmer, JG; Lovell, MA | 1 |
| Chen, GQ; Chen, Z; Jing, Y; Styblo, M; Walton, F; Waxman, S; Weinberg, R; Zhou, L | 1 |
| Gong, Z; Le, XC; Lu, X; Wang, Z; Zhou, J | 1 |
| Au, WY; Chan, CH; Chim, CS; Fung, AT; Kwong, YL; Liang, RH; Ma, ES; Wong, KF | 1 |
| Fukai, Y; Hirata, M; Ichikawa, N; Kaise, T; Kinoshita, K; Kobayashi, H; Ohta, S; Saitoh, H; Sakurai, T; Ueno, M | 1 |
| D'Andrea, DM; Darwish, M; Porter, JM; Remick, SC; Sweeney, CJ; Takimoto, C; Tracewell, WG; Wood, L | 1 |
| Cao, F; Chen, B; Le, XC; Lu, X; Shen, S; Yuan, C; Zhou, J | 1 |
| Liu, Z; Sun, G; Wang, F; Wang, H; Wang, Y; Xi, S; Xu, Y; Yang, Y; Zheng, Q; Zheng, Y | 1 |
| Hu, C; Jiang, F; Li, Y; Li, Z; Mu, J; Ning, S; Si, L; Wang, X; Ye, X | 1 |
| Bu, N; Cao, FL; Naranmandura, H; Wang, QQ; Zhang, YF; Zhou, J; Zhou, XY | 1 |
| Hu, YH; Li, SG; Niu, Q; Ren, QX; Wang, HX; Xu, MC | 1 |
| Chen, H; Gao, C; Gao, Y; Guo, M; Guo, S; Hai, X; Lin, L; Wang, X; Wu, Z | 1 |
1 trial(s) available for arsenic trioxide and isomethyleugenol
| Article | Year |
|---|---|
Arsenic speciation in urine from acute promyelocytic leukemia patients undergoing arsenic trioxide treatment.
Topics: Adult; Antineoplastic Agents; Arsenic; Arsenic Trioxide; Arsenicals; Arsenites; Cacodylic Acid; Chromatography, High Pressure Liquid; Humans; Injections, Intravenous; Leukemia, Promyelocytic, Acute; Male; Methylation; Middle Aged; Oxidation-Reduction; Oxides | 2004 |
14 other study(ies) available for arsenic trioxide and isomethyleugenol
| Article | Year |
|---|---|
Relation between airborne arsenic trioxide and urinary excretion of inorganic arsenic and its methylated metabolites.
Topics: Adult; Air Pollutants, Occupational; Arsenic; Arsenic Trioxide; Arsenicals; Chemical Industry; Humans; Male; Methylation; Oxides | 1992 |
[Effect of S-adenosylmethionine on methylation of inorganic arsenic].
Topics: Animals; Arsenic; Arsenic Trioxide; Arsenicals; Cricetinae; Liver; Male; Mesocricetus; Methylation; Oxides; S-Adenosylmethionine | 1990 |
Metabolism and excretion of orally administrated arsenic trioxide in the hamster.
Topics: Animals; Arsenic; Arsenic Trioxide; Arsenicals; Cacodylic Acid; Cricetinae; Erythrocytes; Kinetics; Male; Mesocricetus; Methylation; Oxides; Plasma; Tissue Distribution | 1985 |
Arsenic speciation in urine from humans intoxicated by inorganic arsenic compounds.
Topics: Adult; Arsenates; Arsenic; Arsenic Poisoning; Arsenic Trioxide; Arsenicals; Cacodylic Acid; Female; Humans; Male; Methylation; Oxides; Time Factors | 1985 |
Methylated metabolites of arsenic trioxide are more potent than arsenic trioxide as apoptotic but not differentiation inducers in leukemia and lymphoma cells.
Topics: Apoptosis; Arsenic Trioxide; Arsenicals; Carcinoma, Hepatocellular; Cell Differentiation; Coculture Techniques; Glutathione Peroxidase; Hematopoietic Stem Cells; Humans; Hydrogen Peroxide; K562 Cells; Leukemia, Promyelocytic, Acute; Liver Neoplasms; Lymphoma; Methylation; Neoplasm Proteins; Oncogene Proteins, Fusion; Oxides; Tumor Cells, Cultured | 2003 |
Serial studies of methylation of CDKN2B and CDKN2A in relapsed acute promyelocytic leukaemia treated with arsenic trioxide.
Topics: Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Case-Control Studies; Cyclin-Dependent Kinase Inhibitor p15; Cyclin-Dependent Kinase Inhibitor p16; Humans; Leukemia, Promyelocytic, Acute; Methylation; Neoplasm, Residual; Oxides; Reverse Transcriptase Polymerase Chain Reaction | 2005 |
Clinical pharmacokinetic study of arsenic trioxide in an acute promyelocytic leukemia (APL) patient: speciation of arsenic metabolites in serum and urine.
Topics: Aged; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Chromatography, High Pressure Liquid; Drug Resistance, Neoplasm; Humans; Injections, Intravenous; Leukemia, Promyelocytic, Acute; Male; Methylation; Oxides; Seafood; Tretinoin | 2006 |
A pharmacokinetic and safety study of intravenous arsenic trioxide in adult cancer patients with renal impairment.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Area Under Curve; Arsenic Trioxide; Arsenicals; Biotransformation; Female; Humans; Karnofsky Performance Status; Kidney Diseases; Male; Methylation; Middle Aged; Neoplasms; Oxides | 2010 |
Arsenic speciation in saliva of acute promyelocytic leukemia patients undergoing arsenic trioxide treatment.
Topics: Adult; Antineoplastic Agents; Arsenates; Arsenic Trioxide; Arsenicals; Arsenites; Cacodylic Acid; Chromatography, High Pressure Liquid; Drug Administration Schedule; Female; Humans; Infusions, Intravenous; Leukemia, Promyelocytic, Acute; Male; Methylation; Middle Aged; Oxides; Saliva; Spectrophotometry, Atomic | 2013 |
Arsenic methylation metabolism and liver injury of acute promyelocytic leukemia patients undergoing arsenic trioxide treatment.
Topics: Adolescent; Adult; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Female; Humans; Leukemia, Promyelocytic, Acute; Leukocytosis; Liver; Liver Function Tests; Male; Methylation; Middle Aged; Oxides; Sex Factors; Young Adult | 2013 |
Induction of the mesenchymal to epithelial transition by demethylation- activated microRNA-200c is involved in the anti-migration/invasion effects of arsenic trioxide on human breast cancer cells.
Topics: Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Breast; Breast Neoplasms; Cell Line, Tumor; Cell Movement; Epithelial-Mesenchymal Transition; Female; Gene Expression Regulation, Neoplastic; Humans; Methylation; MicroRNAs; Neoplasm Invasiveness; Oxides; Up-Regulation | 2015 |
Methylated arsenic metabolites bind to PML protein but do not induce cellular differentiation and PML-RARĪ± protein degradation.
Topics: Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Biotransformation; Cacodylic Acid; Cell Differentiation; Cell Proliferation; Dose-Response Relationship, Drug; HEK293 Cells; HeLa Cells; Humans; Leukemia, Promyelocytic, Acute; Methylation; Nuclear Proteins; Oncogene Proteins, Fusion; Organometallic Compounds; Oxides; Promyelocytic Leukemia Protein; Proteasome Endopeptidase Complex; Protein Binding; Protein Interaction Domains and Motifs; Proteolysis; Sumoylation; Time Factors; Transcription Factors; Tumor Suppressor Proteins | 2015 |
Effects of Proanthocyanidins on Arsenic Methylation Metabolism and Efflux in Human Hepatocytes L-02.
Topics: Arsenic; Arsenic Trioxide; Biological Transport; Gene Expression Regulation; Glutathione; Hepatocytes; Humans; Methylation; Methyltransferases; Multidrug Resistance-Associated Proteins; Oxidation-Reduction; Proanthocyanidins | 2019 |
Monomethylated arsenic was the Major methylated arsenic in Red blood cells of acute promyelocytic leukemia patients treated with arsenic trioxide.
Topics: Adolescent; Adult; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Biotransformation; Cacodylic Acid; Child; Child, Preschool; Chromatography, High Pressure Liquid; Erythrocytes; Female; Hemoglobins; Humans; Infant; Infant, Newborn; Leukemia, Promyelocytic, Acute; Male; Methylation; Middle Aged; Protein Binding; Spectrometry, Fluorescence; Spectrophotometry, Atomic; Young Adult | 2021 |